The number of people with susceptibility test result for rifampicin in Viet Nam

Viet Nam: The number of people with susceptibility test result for rifampicin was 88.85 in 2021. ▲ Rising

Latest (2021)
88.85
Change on year
up 4.0%
World rank
72nd
of 146 countries
All-time high
88.85
in 2021
All-time low
60.39
in 2017
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Viet Nam, 2017–2021

0204060802017201920212017: 60.42018: 82.12019: 75.12020: 85.42021: 88.8

Source: World Health Organization, Global Health Observatory.

Analysis

In 2021, the number of people with susceptibility test result for rifampicin in Viet Nam stood at 88.85. That is the highest value across all 5 years on record.

That represents a change of up 4.0% on the previous year and up 47.1% over five years.

Viet Nam ranks 72nd of 146 countries on this measure, in the middle of the range.

The number of people with susceptibility test result for rifampicin in Viet Nam, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. in Viet Nam, 2017 to 2021.
Year Value Change
2017 60.39
2018 82.1 +36.0%
2019 75.14 -8.5%
2020 85.44 +13.7%
2021 88.85 +4.0%

Viet Nam compared with similar countries

  • Viet Nam's 88.85 is below the median for upper middle income countries, which is 92.7, 96% of the median. (45 countries reporting)
  • Viet Nam's 88.85 is below the median for East Asia & Pacific, which is 96.47, 92% of the median. (28 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 72.54 60.39 82.1 3
2020s 87.14 85.44 88.85 2

Countries ranked near Viet Nam

  1. 69 Romania 89.23 compare
  2. 70 Guinea-Bissau 89.04 compare
  3. 71 Egypt 89 compare
  4. 73 Philippines 88.57 compare
  5. 74 Benin 87.94 compare
  6. 75 United Kingdom of Great Britain and Northern Ireland 87.93 compare

See the full ranking of 148 places →

More health data for Viet Nam

All data for Viet Nam →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Viet Nam?
The number of people with susceptibility test result for rifampicin in Viet Nam was 88.85 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Viet Nam?
The highest recorded value was 88.85 in 2021.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Viet Nam?
The lowest recorded value was 60.39 in 2017.
How does Viet Nam rank for the number of people with susceptibility test result for rifampicin?
Viet Nam ranks 72nd out of 146 countries with data for 2021.
Where does this Viet Nam data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Viet Nam. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/viet-nam/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/viet-nam/">The number of people with susceptibility test result for rifampicin in Viet Nam</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed